CareLit · DOI-Nachweis · Zeitschrift für Gastroenterologie
Impact of interferon-alpha in combined chemoradioimmunotherapy for pancreatic adenocarcinoma (CapRI): First data from the immunomonitoring
DOI 10.1055/s-2006-950730
Bibliografische Angaben
Nachweis in CareLit
Autor:innenA Märten, D Jäger, M Büchler, J Schmidt
ZeitschriftZeitschrift für Gastroenterologie
Ausgabe09/2006
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Data from a phase II trial combining chemoradiotherapy with IFN-alpha (CapRI scheme) for adjuvant treatment of pancreatic carcinoma are very encouraging. Therefore, a phase III trial comparing chemotherapy with the CapRI scheme has been initiated in August 2004. Translational research with a focus on immunomodulation is performed in parallel to the study. Blood and serum samples are taken at various time-points. Pat…
Zitieren
Zitierempfehlung
A Märten, D Jäger, M Büchler, J Schmidt (2006) Impact of interferon-alpha in combined chemoradioimmunotherapy for pancreatic adenocarcinoma (CapRI): First data from the immunomonitoring. Zeitschrift für Gastroenterologie (09). https://doi.org/10.1055/s-2006-950730
Mit CareLit weiterarbeiten